StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb Co. (BMY) PT Raised to $74 at BMO Capital
February 7, 2022 7:21 AM
BMO Capital analyst Evan David Seigerman raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $74.00 (from $72.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
UPDATE: Bristol-Myers Squibb Co. (BMY) PT Raised to $76 at Goldman Sachs
February 7, 2022 5:16 AM
Bristol-Myers Squibb Co. (BMY) PT Raised to $73 at Wolfe Research
February 7, 2022 3:51 AM
Form 8-K BRISTOL MYERS SQUIBB CO For: Feb 04
February 4, 2022 7:51 AM
2022 Product Launches Will Provide Good Foundation for Bristol-Myers Squibb's (BMY) Future Growth, Reiterate Outperform - BMO Capital
February 4, 2022 7:49 AM
Bristol Myers posts slightly better-than-expected 4th-qtr results
February 4, 2022 7:00 AM
Bristol-Myers Squibb (BMY) Tops Q4 EPS by 1c
February 4, 2022 6:59 AM
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
February 4, 2022 6:59 AM
